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PreviewsRNAi: RISC Gets Loaded
When an siRNA or miRNA proceeds through the RNA-
induced silencing complex assembly pathway, only
one of the two w21-nucleotide RNA strands survives
in the final, active complex. In this issue of Cell, Mat-
ranga et al. (2005) and Rand et al. (2005) reveal the
fate of the rejected passenger siRNA strand. Addi-
tionally, Gregory et al. (2005) define a heterotrimeric
complex from humans that appears to execute dsRNA
loading, strand selection, and target mRNA cleavage
activities.
During RNA interference (RNAi), the RNA-induced si-
lencing complex (RISC) assembly machinery faces a
formidable challenge: to program an RNA endonucle-
ase on demand to specifically target a genomic invader
or endogenous transcript (for a recent review, see Fili-
powicz, 2005). These duties require the machinery to
abstract from a long double-stranded RNA (dsRNA) a
single-stranded RNA that is appropriately sized to con-
fer specificity and then use it to guide target destruc-
tion. In this issue of Cell, Gregory et al. (2005), Matranga
et al. (2005), and Rand et al. (2005) illuminate this pro-
cess and reinforce the multitalented nature of the
known RNAi components.
The dsRNAs that naturally initiate RNAi are pro-
cessed by a Dicer (Dcr) family RNase III enzyme into
w20–25-nucleotide (nt) duplexes. These duplexes are
called small interfering RNAs (siRNAs) if they are per-
fectly complementary and arise from long dsRNA or
microRNAs (miRNAs) if they are imperfectly base-
paired and arise from pre-miRNA hairpins. siRNA and
miRNA duplexes are converted into a single-stranded
form as they assemble into the RISC, where they pro-
vide the sequence specificity or “guide” for mRNA deg-
radation. This transition from a double- to a single-
stranded silencing trigger has been one of the more
mysterious phases of the RNAi pathway, and the un-
winding step itself has been frequently attributed to an
unidentified ATP-dependent helicase. In this issue of
Cell, Matranga et al. (2005) and Rand et al. (2005) now
show that in at least some cases, dsRNA unwinding
and RISC loading is facilitated by cleavage of the unin-
corporated “passenger” strand by Ago2 (Figure 1A).
An siRNA duplex is analogous to the duplex formed
between the guide and the mRNA target within active
RISC. This simple insight prompted Matranga et al.
(2005) and Rand et al. (2005) to ask an intriguing ques-
tion: does the passenger strand of an siRNA serve as
the first target of RISC? Based on the site specificity
of the endonuclease activity of RISC, siRNA cleavage
would be predicted to yield 9- and 12-nt hydrolysis
products with 5#-phosphate and 3#-hydroxyl termini.
Both groups observed the predicted 9-nt 5# cleavage
product. Furthermore, cleavage was largely limited to
the passenger strand that was thermodynamically dis-
favored for RISC assembly, in keeping with knownsiRNA asymmetry rules. Finally, siRNA cleavage pre-
ceded unwinding, as antisense RISC inhibitors that
block binding and cleavage of targets after siRNA un-
winding fail to protect the passenger strand.
Having left no doubt that passenger-strand cleavage
occurs, Matranga et al. (2005) and Rand et al. (2005) go
on to consider an important question: how critical is
passenger-strand cleavage to the RISC assembly path-
way? This question is all the more pressing because of
evidence that three of the four Argonaute proteins in
humans (Ago1, Ago3, and Ago4) lack endonuclease ac-
tivity but are nonetheless loaded with single-stranded
guide RNAs (Liu et al., 2004; Meister et al., 2004). Simi-
larly, single-stranded miRNAs associate with Ago2, de-
spite the expectation that mismatches within the
unwound precursor should block passenger-strand
cleavage activity of Ago2. To address this issue, Mat-
ranga et al. (2005) challenged the Drosophila RNAi ma-
chinery with siRNA carrying a phosphorothioate group
at the passenger-strand cleavage site. This modifica-
tion reduced the rate of passenger-strand hydrolysis by
more than an order of magnitude. The rate of RISC as-
sembly with these modified siRNAs (as measured by
siRNA unwinding) was reduced approximately 3-fold
relative to the unmodified control. This relatively mod-
est effect led to significant impairment of RISC assem-
bly at early time points. The phosphorothioate inhibition
was more pronounced in human extracts, which are
less efficient at assembling RISC. Similarly, when Rand
et al. (2005) blocked passenger-strand cleavage with
site-specific 2#-O-methyl modifications, they observed
a reduction in RISC activity that correlated with the loss
of the 9-mer product. They also showed that an active-
site mutation in Ago2 that crippled the endonuclease
activity impeded passenger-strand release. Together,
the two studies indicate that passenger-strand cleav-
age plays a significant role in the formation of active
Ago2-containing siRNA-programmed RISC (Figure 1A,
left). However, the nonessential nature of passenger-
strand hydrolysis led Matranga et al. (2005) to propose
a slower, cleavage-independent “bypass” mechanism
for RISC assembly (Figure 1A, right).
In contrast to the siRNA pathway, miRNAs are loaded
into RISC entirely via the cleavage-independent “by-
pass” mechanism (Figure 1B). Matranga et al. (2005)
again used phosphorothioate substitution to block pas-
senger-strand cleavage in duplexes with varying de-
grees of miRNA-like character. This analysis showed
that the degree of base-pairing of the so-called “seed”
region of the guide (nts 2–8) is a key determinant in
channeling the duplex into either the cleavage-depen-
dent or cleavage-independent pathway.
In the course of their investigations into RISC activa-
tion, Rand et al. (2005) cast unexpected doubt on the
roles of ATP during this process. When RNAi is ana-
lyzed in unfractionated Drosophila embryo lysates, ATP
appears to function at multiple stages of the RNAi path-
way (Filipowicz, 2005), including the progression of the
RISC-loading complex (RLC) intermediate into holo-
RISC (Pham and Sontheimer, 2005 and references
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544Figure 1. Mechanisms of Guide RNA Loading and Activation within RISC
(A) In Drosophila, perfectly base-paired siRNAs proceed through the RISC-loading complex (RLC) and engage Ago2. The precise details of
the assembly of this complex are unknown. Passenger-strand cleavage by Ago2 precedes and presumably facilitates siRNA strand dissoci-
ation (left), leading to the formation of siRNA-programmed RISC (siRISC) that goes on to target the cleavage of specific mRNA. A slower,
cleavage-independent “bypass” pathway (right) also generates active siRISC, perhaps by unwinding of the siRNA (yellow spiral arrow). The
passenger strands are degraded by cellular nucleases.
(B) In Drosophila, imperfectly base-paired miRNA precursors generally assemble into Ago1-containing miRNA-programmed RISC (miRISC),
perhaps through an miRISC-loading complex (miRLC). In this case, the bulges and mismatches in the duplex prevent passenger-strand
cleavage, and the active miRISC forms via the cleavage-independent route.
(C) Affinity purification of Dicer-containing complexes from human cells indicates the existence of an assembly consisting of Dicer (hDcr),
TRBP, and hAgo2. This complex is capable of dicing dsRNA precursors, loading the guide strand into hAgo2, and cleaving mRNA targets,
suggesting that it may function as a form of RISC.therein). It has been presumed that the reported ATP
requirement for progression beyond the RLC reflects an
ATP-dependent RNA helicase activity that unwinds the
siRNA. In contrast to the embryo lysate results, Rand
et al. (2005) observed no absolute requirements for ATP
in siRNA-programmed Drosophila S2 cell extracts.
These results are surprising not only because they dif-
fer from those seen in embryo lysates but also because
RNA duplexes as short as several base pairs (such as
those found in the spliceosome) require ATPases for
unwinding. The authors conclude that, in S2 cell ly-
sates, RISC assembly per se does not require ATP. In
this case, siRNA unwinding during RISC activation
could be driven in part by the binding energy that is
released as Ago2 engages the siRNA guide strand. To
explain the conflicting ATP requirements of RISC as-
sembly in lysates from S2 cells and embryos, Rand et
al. speculate that ATP is required to maintain the 5#-
phosphorylated state of siRNAs in the presence of an
embryo extract-specific phosphatase. This explanation
seems incomplete, as recent native gel analyses indi-
cate that holo-RISC assembly requires ATP even when
the integrity of the siRNA 5#-phosphate is directly moni-
tored with a radiolabel (Pham and Sontheimer, 2005).
Given that the S2 cell extracts are prepared as S100
postribosomal supernatants, they probably assemble
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Tore minimal forms of RISC than the holo-RISC ob-
erved in embryo lysates; perhaps holo-RISC assembly
equires ATP, whereas formation of the smaller active
omplexes does not.
From these two papers, it appears that the world of
he RNAi machinery may be getting smaller: in at least
ome cases, Ago2 may partially substitute for the hy-
othetical helicase thought to be involved in RISC
ctivation. Still, many questions remain. Is the cleav-
ge-independent “bypass” pathway related to the ATP-
ependent mechanism that stimulates multiple turn-
ver (Haley and Zamore, 2004), and if so, what is the
elevant ATPase? To what extent are the cleavage and
ypass mechanisms in kinetic competition with each
ther? As weak 5#-end base pairing by the guide strand
eems to obviate the need for passenger cleavage, and
s many Ago proteins are inactive as endonucleases,
an we really tell which is the “primary” mechanism for
ISC loading and which is the “bypass”?
The first two papers suggest that the most familiar
rosophila RNAi proteins—Dcr-2, the dsRNA binding
omain (dsRBD) protein R2D2, and Ago2—may collec-
ively fulfill more functions than previously thought. In
third paper in this issue of Cell, Gregory et al. (2005)
ut the human orthologs of these three proteins (hDcr,
RBP, and hAgo2, respectively) to the test and provide
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545evidence that they comprise the minimal machinery re-
quired for a complete RNAi response. In this study, the
authors identified only two proteins that specifically co-
purified with epitope-tagged hDcr: TRBP and hAgo2.
The purified ternary complex could be programmed
with either exogenous siRNA or unprocessed dsRNA to
recapitulate RNAi activity in vitro (Figure 1C). Thus, it
appears that the minimal RNAi machine in humans has
shrunk to the familiar trinity—hDcr, TRBP, and hAgo2—
though the participation of low-abundance copurifying
factors has not yet been categorically excluded. We
await the final nail in the coffin: the production of an
entirely recombinant human RNAi machine, which
should now be achievable.
The current study also bolsters the possibility that
hDcr/TRBP can play a role as a RISC-loading platform,
despite the fact that mammalian Dcr is not strictly re-
quired for an siRNA response (Kanellopoulou et al.,
2005; Murchison et al., 2005). In particular, Gregory et
al. (2005) found that the preassembled ternary complex
is significantly more potent when programmed with a
dsRNA processing substrate than with a “pre-diced”
duplex. Although this idea is not new (Rose et al., 2005
and references therein), this study adds biochemical
credence to the notion of direct coupling between
dsRNA processing and RISC loading as an autono-
mous function of hDcr/TRBP.
For its final trick, the minimal RNAi machine charac-
terized by Gregory et al. (2005) could take up an siRNA
and cleave a cognate target without the aid of ATP, sim-
ilar to the observations of Rand et al. (2005) in Drosoph-
ila S2 lysates. The authors estimate that, even in the
absence of ATP, the purified complex could carry out
multiple rounds of catalysis, though ATP boosted RISC
activity. Preliminary analyses with GTP, nonhydrolyz-
able ATP analogs, and even pyrophosphate and inor-
ganic phosphate indicate that we still have much to
learn about possible roles of NTP binding and hydroly-
sis in the human RNAi pathway.
Taken together, these three studies suggest a simpli-
fied view of siRNA-programmed RISC activation and
posit a minimal, three-component RNAi machine that
nominally fulfills the basic biochemical requirements of
a silencing response (dicing dsRNA, separating the two
strands, and executing multiple rounds of mRNA cleav-
age). Still, questions remain about accessory factors
that could serve to grease the machine’s wheels or
adapt it for multiple silencing outputs (Filipowicz, 2005).
Genetic and biochemical data have implicated a host
of proteins in both Drosophila and humans as compo-
nents of mature, active forms RISC. It remains to be
seen what new functions these other factors confer to
RNAi machines, and how they modulate the biochemi-
cal steps that are executed by the core Dicer/dsRBD
protein/Argonaute heterotrimer.
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